Saudi healthcare sector .. Price gaps blow investment opportunities

The Saudi financial market is a witness to an overlap between caution and anticipation, but the healthcare sector still proves its flexibility as one of the most prominent defense sectors, supported by demographic and economic transformations that increase the long -term growth opportunities within the target of “Saudi vision 2030”. Data collected by “Al -Sharq” from “Bloomberg” and “Arkam” shows that most of the listed businesses still trade at lower price levels than the target average that analysts value analysts, which means there is a positive gap that can provide opportunities to reward in the future. In the arrangement based on the difference between the market price and the average research recommendations, the “SMC” health rating in the lead had a possible increase in the market price of 48%, despite the limited number of recommendations to only two. Financial analyst Mohamed Al -Maimouni said that “the level of great optimism to” SMC “reflects the confidence of analysts in the flexibility of her business model and the ability to have sustainable expansion, as it has a successful mix between direct operation and strategic alliances, which gives it an operating efficiency that reflects on the last profit margin.” He added that “despite the positive view, the company faces challenges, especially the high operating costs and competition for medical cadres, in addition to the importance of keeping stable profit margins and efficient expansion management to avoid pressure on cash flow and return on shareholders’ rights.” As for the member of the Saudi Economics Association, Seed Al -thaqfan, he said that “the company’s profitability is more than 30 times more than 30 times, but the company has great extensions in the city of Riyadh by adding 3 new hospitals and increasing nearly 700 beds, increasing the revenue and future of the future.” Saudi German. Growth is supported by attractive evaluation and strategic expansion in second place, the share of the ‘Saudi German Health’ arrow as one of the most prominent names in the investment scene of the Saudi health sector, as the major difference of 42% the current price of the share (57.8 Riyers) and the average recommendations (82.21 Riyals) The homes of the houses of the houses The houses of the houses of the major difference in the average of the average, the average recommendations in the operation of the houses of the houses of the houses of the houses of the houses of the houses of the houses of the housing of the houses of the houses of the houses of home housing. upcoming periods. According to financial analyst Mohamed Al -Maimouni, the positive view of the arrow in his interview with Al -Sharq is based on basic and regulatory factors. At the basic level, the company’s geographical expansion strategy within and outside the Kingdom supports its growth opportunities by achieving areas with high demand and limited medical services, increasing its market share. As far as the organizational and demographic level is concerned, the expansion of health insurance programs and the high percentage of beneficiaries increases the demand for private sector services, which is what the company benefits from its strong structure and wide distribution. Al -Maimouni pointed out that the stock still has an evaluation appeal, as the current price does not reflect the potential of the underlying growth, despite improving income and operating margins. The company is also characterized by a balanced position that makes it a preferred choice for both individual and institutional investors, as it is not a high price companies that are difficult for individuals to enter, nor does small businesses at high risk, giving them a double attraction for the investor who is looking for sustainable growth and short return. Al -Maimouni concludes that the arrow combines an attractive evaluation, strong basic principles, constant expansion and economic and organizational support, which justifies positive recommendations with pride goals exceeding current levels. As for “Al -Hammadi”, it was third, with a difference of 35%. Other companies were followed on the rankings, including ‘Mouwasat’, which recorded a difference of 21%and ‘sponsorship’, showing a difference of 10%. Medical Fakih .. High profitability, “Fakih”, with a mixture of opportunities and dangers, with a difference of 16%. A member of the Saudi Economics Association, Saad Al -thaqfan, believes that the difference between the current and the target price is low due to the high profitability more than 30 times, in addition to moderate future growth of the company, which limits a significant decline in duplicate and increases future price expectations according to the estimate of artisans. This is compared to the ‘Saudi German’ company, which trades at a leg of almost 20 times (except uncomplicated profits), with a strong expectation of the growth of income and profits, which reduces repeated and increasing the expected future price of the share. The share of the largest company in the sector has 15% increasing opportunities. As for the ‘Habib’, the largest businesses in the market value and the share price of 267.4 Riyals, it had more conservative recommendations, as the difference between the current price and the average recommendations reached only 15%. The first financial analyst in Al -Eqtisadiah newspaper, Majed Al -khaldi, believes that the share of “Al -Habib” reduced his losses during the current year after beating 227 Riyals when he was repeated by a lower profit for the past two weeks. It is likely that the profits of the next two quarters will stimulate the performance of the share with the possibility of reaching levels that are approaching 300 Riyals, which is the most likely value based on the expected performance for the current year, as new expansions will contribute to the growth of business with more than 20% compared to 17.8% recorded in 2024. About 1%higher, and “al -mousa” is about 6%. Financial analyst Majid Al -khalidi indicates that “Dallah’s Health” is a candidate to achieve quarterly turnover for the second quarter in succession, and uses new acquisitions and expansion, but it will not be expected to achieve a wide growth in the net profit due to the high cost of projects and the continued losses of the Dallh Hospital, early surgery. He also sees that the share is trading near the average expectations of analysts, but that any positive developments that exceed the estimates can push it to higher levels, especially as it still trades at the lower profitable repetition of the average of the past five years, as well as a 4.1 -time border, which is supporting levels than the quarterly results are better than expected. Despite the difference in assessments, analysts unanimously agree that the Saudi health sector has become a balanced investment option that combines stability and returns, which benefit from expansion policies in insurance programs and raising public health spending. The different structures of the sector provide a broader area for investors to distribute their governor among growth companies nominated for a strong rise, and others that produce a sustainable return, which reflects the maturity of the fast Saudi market and the increasing attraction on the regional and international level. The company’s health sector businesses share the price at the end of yesterday’s session, which corresponds to October 6, 2025 (SAR) Average target price (SAR) number of recommendations, the change rate between the current price and the target price is repeated profitability (once) SMC 20.05 29.60 2 48% 33.18 German 57.8 82.21 8 42% 13.55 all Hammadi 34. 18.96.96 Signatures 74.9 90.84 14 21% 21.37 Care 180 198.59 9 10% 25.82 FAKIH 42.04 48.84 8 16% 32.99 Sulaiman Al Habib 267.4 308.04 15 15% 39.70 Dalle 146.3 145.38 9-1% 28.58 Mousa 179.7 168 4-6% 43.07